Athens insomnia scale

From WikiMD's Medical Encyclopedia

Revision as of 18:24, 18 March 2025 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

The Athens Insomnia Scale (AIS) is a widely used medical tool to assess insomnia symptoms in individuals with sleep disorders. Introduced in 2000 by a group of researchers from Athens, Greece, the AIS helps healthcare professionals evaluate the severity of insomnia and monitor treatment progress.

Overview[edit]

The Athens Insomnia Scale consists of eight items that measure various aspects of insomnia, including:

  • Sleep induction (difficulty falling asleep)
  • Awakening during the night
  • Early morning awakening
  • Total sleep duration
  • Sleep quality
  • Sense of well-being during the day
  • Functioning during the day
  • Sleepiness during the day

Each item is rated on a 0-3 scale, with 0 indicating no problem and 3 indicating a severe problem. The total score ranges from 0 to 24, with higher scores indicating more severe insomnia.

Scoring and Interpretation[edit]

The Athens Insomnia Scale is designed to be self-administered by the patient. Scores for each item are added together to obtain a total score, which can be interpreted as follows:

  • 0-5: No significant insomnia
  • 6-10: Mild insomnia
  • 11-15: Moderate insomnia
  • 16-24: Severe insomnia

A total score of 6 or higher typically indicates the presence of clinically significant insomnia, warranting further evaluation and possible intervention.

Applications[edit]

The Athens Insomnia Scale is commonly used in clinical practice and research settings to:

  • Assess the severity of insomnia symptoms
  • Monitor changes in insomnia symptoms over time or in response to treatment
  • Screen for insomnia in individuals with sleep complaints or other medical conditions associated with sleep disturbances
  • Aid in the diagnosis of insomnia and other sleep disorders

Limitations[edit]

While the Athens Insomnia Scale is a valuable tool in assessing insomnia, it has some limitations:

  • It is a self-report measure, which may be subject to bias or inaccurate reporting.
  • It may not capture all aspects of an individual's sleep experience or the specific causes of their insomnia.
  • It does not replace a comprehensive clinical evaluation, including a detailed sleep history, physical examination, and, if necessary, diagnostic testing such as polysomnography.

See Also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.